UCB, Otsuka to Focus on Therapeutic Area of CNS Disorders

Otsuka Pharmaceutical and UCB have agreed to focus their collaboration on the therapeutic area of central nervous system (CNS) disorders and to discontinue their collaboration in immunology.
PBR